Lilly Employer Program For Zepbound Seeks Broader Coverage Without PBMs

Lilly hopes the program will significantly add to employer-sponsored coverage of obesity drugs. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from PBMs

More from Market Access